X4 Pharmaceuticals, Inc. (XFOR) NASDAQ
4.04
-0.07(-1.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.04
-0.07(-1.70%)
Currency In USD
| Market Cap | 169.17M |
| Enterprise Value | 29.41M |
| P/E Ratio | -5.12 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 42.27 |
| Price/Book Ratio | 3.03 |
| Enterprise/Revenue | 18.29 |
| Enterprise/EBITDA | -1.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -11.06 |
| Operating Margin | -10.84 |
| Return On Assets | -0.37 |
| Return On Equity | -0.95 |
| Revenue | 35.11M |
| Revenue/Share | 0.07 |
| Gross Profit | 28.86M |
| EBITDA | -85.61M |
| Net Income | -79.2M |
| Diluted EPS | -1.87 |
| Total Cash | 233.72M |
| Total Cash/Share | 1.85 |
| Total Debt | 733,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.18 |
| Book Value Per Share | 1.33 |
| 52-Week Change | 6.04 |
| 52-Week High | 4.83 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 4.13 |
| Moving Average 200 Days | 3.74 |
| Average Volume | 423,252 |
| Shares Outstanding | 94.32M |
| % Held by Institutions | 213.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | April 28, 2025 |